Newsletter Subject

The Miracle of Cannabis

From

wealthdaily.com

Email Address

newsletter@wealthdaily.com

Sent On

Tue, Oct 30, 2018 06:54 PM

Email Preheader Text

Researchers in Australia are making headway in examining the effects of cannabis on brain and centra

Researchers in Australia are making headway in examining the effects of cannabis on brain and central nervous system tumors. The results so far are astounding... and the next stage of research has the potential to be a miracle medical breakthrough. You are receiving this email because you subscribed to Wealth Daily. [Click here]( to manage your e-mail preferences. [Wealth Daily logo] The Miracle of Cannabis [Monica Savaglia Photo] By [Monica Savaglia]( Written Oct. 30, 2018 Rarely do we hear about medical breakthroughs. But when we do, we know our lives are about to change... that there will be new medical advances on the horizon that help treat diseases that affect us all. There’s one disease that’s probably affected you in one way or another: cancer. Whether you have firsthand experience with the disease or you’ve seen a friend or family member go through the turmoil of having cancer, you know how devastating it can be. I know when there’s something wrong with me, I can’t help but think it might be something so much worse. Both of my grandmothers passed away from cancer. The disease has hit home for me. I would never want anyone to have cancer or spend their lives worried that they could be diagnosed again if they beat the disease. Hurry! Pot Stocks to Surge on November 6th! On November 6th, Michigan is set to make a historic announcement about marijuana. With the stroke of a pen, the state will legalize pot for recreational use... And instantly create a multibillion-dollar market, potentially sending a group of pot stocks skyrocketing by 1,000% in very short order. We’ve narrowed down the most lucrative pot opportunities that are primed to soar. I'm urging you not to wait any longer... [Click here to get started.]( The Fight Against Cancer The American Cancer Society has estimated that 1,735,350 new cancer cases will be diagnosed in the U.S. in 2018. In addition to that, 609,640 cancer deaths will happen in 2018 in the U.S. These are hard statistics to realize. The likelihood is high that many of us know someone who will have to alter their entire life to fight cancer. What’s even more terrifying is that an estimated 16,830 adults (9,490 men and 7,340 women) will die from primary cancerous brain and central nervous system (CNS) tumors this year, according to Cancer.net. A primary brain or spinal cord tumor is a tumor that starts in the brain or spinal cord. There are also secondary brain tumors, which start somewhere else in the body and spread to the brain. Cancer.net reports that brain and other nervous system cancer is the 10th leading cause of death for women. The odds that you might know someone or you yourself could have a brain or central nervous system (CNS) tumor are increasing. But what if there was something that could help brain tumor patients? Well, the medical breakthrough could be just around the corner. Cannabis Kills Brain Cancer Cells Researchers have been conducting tests on the effects of cannabis on brain cancer cells. Those researchers learned that cannabis can kill cancer in the lab, so now they’re hoping for a breakthrough that proves it will be able to kill brain cancer cells in live patients. This is incredible news! These researches saw cannabis killing brain cancer cells in Petri dishes, which has given Australian researchers the incentive to further the discovery. Australian researchers will be embarking on a clinical trial to find out if cannabis can also kill brain cancer cells in live patients. Up to 82 patients suffering from glioma, an aggressive form of brain tumor, will have the opportunity to assist in medical research. These 82 patients will begin to take high-THC medical cannabis orally for three months, while still undergoing their standard treatment. Tumors aren’t easy to treat because on average, they contain 100 different types of cancer cells. Neurosurgeon and trial key investigator Michael Sughrue says, “We know our drugs work on some, but not all of them. So we need more bullets in our gun essentially.” The idea behind cannabis as a form of treatment is to slow the growth of tumors and improve a patient’s life. But that’s not all — researchers and doctors are hoping cannabis will be able to kill the cancer cells and prevent a recurrence. Imagine never having to worry about cancer again... never wondering if it’ll come back and rearrange your life again. That would be every cancer patient’s dream. Stock Market Millionaire Reveals Top Pot Stock of the Decade If you’ve ever thought about investing in legal marijuana, now is the perfect time. Millionaires are being minted overnight. Stocks are exploding 500%... 1,000%... even 10,000%! The market is still young, but we’re already starting to see the cream rise to the top. And one pot stock is so strong that bestselling author and self-made millionaire Brian Hicks is calling it “the pot stock of the decade.” [Click here to find out why!]( The Miracle of Cannabis There’s a lot of research being conducted on cannabis right now. One of the top priorities is understanding how the drug affects our health. We haven’t known the potential of cannabis until the past few years. And in those past few years, it has been amazing to witness the type of information and research that’s emerged. It’s been somewhat of a phenomenon. And it’s going to stick around and benefit humankind. The trial that is being conducted by Dr. Sughrue at the Endeavour College of Natural Health is going to prove that. And it’s obvious that people believe in the potential of cannabis. Patients are lining up for the trial at Endeavour College. One of those patients is Lyn Boyle, who has been “dead against” marijuana for all her life. She was diagnosed with glioma in 2013 and is willing to see what cannabis has to offer her and her health. Australia might be ahead of other countries in its research on the effects of cannabis on cancer and tumors, but that doesn’t mean other countries are far behind. All this research and new medical treatment is going to spark a huge industry boom for medical marijuana. We’re at the very beginning of something really exciting, and I can’t wait to see the future treatments and investing opportunities. Cannabis is changing it all. Until next time, [Monica Savaglia] Monica Savaglia Monica Savaglia is Wealth Daily’s IPO specialist. With passion and knowledge, she wants to open up the world of IPOs and their long-term potential to everyday investors. She does this through her newsletter [IPO Authority](, a one-stop resource for everything IPO. She also contributes regularly to the [Wealth Daily]( e-letter. To learn more about Monica, [click here.]( Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [Last Chance for Pot Stocks?]( [Forget Amazon (NASDAQ: AMZN) Stock: These Payments Are Guaranteed]( [The Three Best Cannabis Stocks to Buy on the Dip]( [Why Every Tesla on the Road Today Is Already Obsolete]( [The Wrong Day...]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Wealth Daily, please add newsletter@wealthdaily.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Wealth Daily](, Copyright © 2018, [Angel Publishing LLC](. All rights reserved. 111 Market Place #720 Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Wealth Daily as well as a link to www.wealthdaily.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Wealth Daily]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.

Marketing emails from wealthdaily.com

View More
Sent On

08/12/2024

Sent On

03/12/2024

Sent On

02/12/2024

Sent On

28/11/2024

Sent On

10/11/2024

Sent On

07/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.